Please provide your email address to receive an email when new articles are posted on . Compared with married people, unmarried people were more likely to have a prolonged QT interval, according to ...
SAN FRANCISCO, CA—Consuming a large quantity of grapefruit juice has effects on the QT interval in healthy adults similar to those seen with moxifloxacin, an antibiotic with known QT-prolonging ...
LQT-1213 is a first-in-class serum glucocorticoid regulated kinase 1 inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum ...
THE case reported below represents a new and very distinct clinical entity. The young patient was observed by us for some years. It was hoped that a similar combination of clinical findings might be ...
BACKGROUND: Left ventricular hypertrophy (LVH) and prolonged QT interval at ECG (QTc) are common in both obesity and arterial hypertension (AH), and are risk factors for cardiovascular disease and ...
Five factors underlie the ongoing overdiagnosis and misdiagnosis of long QT syndrome (LQTS), including temporary QT prolongation following vasovagal syncope, a "pseudo"-positive genetic test result, ...
Thirty healthy volunteers and ten patients with congenital long QT syndrome participated in a four-day thorough-QT-study. On days one and three, study subjects received no study drugs and underwent ...
As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...
I think there's no reason why the test in principle shouldn't be just as easy to perform as a treadmill stress test. Ackerman said that at his center, patients with suspected LQTS are worked up with a ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Patients who drank 2 L grapefruit juice within several hours had significant corrected QT ...
MONTREAL, Aug. 25, 2023 /PRNewswire/ - Thryv Therapeutics Inc. today announced positive results of the WAVE 1 Proof of Concept clinical study evaluating LQT-1213 for the reduction of QTcF in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results